Citations (8)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Saubashya Sur, Tanushree Patra, Mistu Karmakar & Anindita Banerjee. (2023) Mycobacterium abscessus: insights from a bioinformatic perspective. Critical Reviews in Microbiology 49:4, pages 499-514.
Read now
Read now
Zhijian Zhang, Wei Wang, Yufeng Wang, Zhongtan Xue, Shanshan Li & Yu Pang. (2022) Inducible Resistance to Amikacin in Mycobacterium abscessus Isolated in Beijing, China. Infection and Drug Resistance 15, pages 2287-2291.
Read now
Read now
Guiqing He, Lianpeng Wu, Qingyong Zheng & Xiangao Jiang. (2022) Antimicrobial susceptibility and minimum inhibitory concentration distribution of common clinically relevant non-tuberculous mycobacterial isolates from the respiratory tract. Annals of Medicine 54:1, pages 2499-2509.
Read now
Read now
Articles from other publishers (5)
Joshua-J. Hunkins, Vinicius-C.-N. de-Moura, Jared-J. Eddy, Charles-L. Daley & Reeti Khare. (2023) In vitro susceptibility patterns for rapidly growing nontuberculous mycobacteria in the United States. Diagnostic Microbiology and Infectious Disease 105:3, pages 115882.
Crossref
Crossref
Ashley R. Rizzo & Nader H. Moniri. (2022) Omadacycline for management of Mycobacterium abscessus infections: a review of its effectiveness, place in therapy, and considerations for use. BMC Infectious Diseases 22:1.
Crossref
Crossref
Keitaro Omori, Hiroki Kitagawa, Kayoko Tadera, Yasuhiko Naka, Shinjiro Sakamoto, Naosuke Kamei, Toshihito Nomura, Norifumi Shigemoto, Noboru Hattori & Hiroki Ohge. (2022) Vertebral osteomyelitis caused by Mycobacteroides abscessus subsp. abscessus resulting in spinal cord injury due to vertebral body fractures. Journal of Infection and Chemotherapy 28:2, pages 290-294.
Crossref
Crossref
Rashmi Gupta, Noora M. S. A. Al-Kharji, Maha A. Alqurafi, Thu Q. Nguyen, Weirui Chai, Pojun Quan, Riya Malhotra, Breven S. Simcox, Phil Mortimer, Leighanne A. Brammer Basta, Kyle H. Rohde & John D. Buynak. (2021) Atypically Modified Carbapenem Antibiotics Display Improved Antimycobacterial Activity in the Absence of β-Lactamase Inhibitors. ACS Infectious Diseases 7:8, pages 2425-2436.
Crossref
Crossref
Mark R. Sullivan, Eric J. Rubin & Charles L. Dulberger. (2021) Mycobacteriophages as Genomic Engineers and Anti-infective Weapons. mBio 12:3.
Crossref
Crossref